| For: | Wietzke-Braun P, Braun F, Sattler B, Ramadori G, Ringe B. Initial steroid-free immunosuppression after liver transplantation in recipients with hepatitis c virus related cirrhosis. World J Gastroenterol 2004; 10(15): 2213-2217 [PMID: 15259068 DOI: 10.3748/wjg.v10.i15.2213] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i15/2213.htm |
| Number | Citing Articles |
| 1 |
Sandeep Mukherjee. Liver Transplantation and Hepatitis C Virus. Transplantation 2005; 80(12) doi: 10.1097/01.TP.0000188357.00666.87
|
| 2 |
Goran B.G. Klintmalm, W. Kenneth Washburn, Steven M. Rudich, Thomas G. Heffron, Lewis W. Teperman, Carlos Fasola, Devin E. Eckhoff, George J. Netto, Eliezer Katz. Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 study. Liver Transplantation 2007; 13(11) doi: 10.1002/lt.21182
|
| 3 |
M Ramos-Casals, J Font. Mycophenolate mofetil in patients with hepatitis C virus infection. Lupus 2005; 14(1_suppl) doi: 10.1177/096120330501400114
|
| 4 |
Alejandra Otero, Evaristo Varo, Jorge Ortiz de Urbina, Rafael Martín-Vivaldi, Valentin Cuervas-Mons, Ignacio González-Pinto, Antoni Rimola, Angel Bernardos, Santiago Otero, Jorge Maldonado, Jose I. Herrero, Elena Barrao, Rosa Domínguez-Granados. A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids. Liver Transplantation 2009; 15(11) doi: 10.1002/lt.21854
|
| 5 |
M Ramos-Casals, J Font. Mycophenolate mofetil in patients with hepatitis C virus infection. Lupus 2005; 14(3_suppl) doi: 10.1191/0961203305LU2122OA
|
| 6 |
Perdita Wietzke-Braun, Volker Meier, Katrin Neubauer-Saile, Sabine Mihm, Giuliano Ramadori. Treatment of genotype 2 and 3 chronic hepatitis C virus-infected patients. World Journal of Gastroenterology 2005; 11(39): 6188-6192 doi: 10.3748/wjg.v11.i39.6188
|
| 7 |
Mazen Alsatie, Naga Chalasani, Paul Y Kwo. Management of Hepatitis C Infection after Liver Transplantation. Drugs 2007; 67(6) doi: 10.2165/00003495-200767060-00004
|
| 8 |
Maximilian Schmeding, Stefan Kienlein, Christoph Röcken, Ruth Neuhaus, Peter Neuhaus, Christoph Heidenhain, Ulf P. Neumann. ELISA-based detection of C4d after liver transplantation — A helpful tool for differential diagnosis between acute rejection and HCV-recurrence?. Transplant Immunology 2010; 23(4) doi: 10.1016/j.trim.2010.06.002
|
| 9 |
Arun Shankar, Graeme Alexander. Liver transplantation for liver disease caused by hepatitis C virus infection. British Journal of Hospital Medicine 2009; 70(2) doi: 10.12968/hmed.2009.70.2.38908
|
| 10 |
M. Schmeding, A. Dankof, V. Krenn, M.G. Krukemeyer, M. Koch, A. Spinelli, J.M. Langrehr, U.P. Neumann, P. Neuhaus. C4d in Acute Rejection After Liver Transplantation—A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence. American Journal of Transplantation 2006; 6(3) doi: 10.1111/j.1600-6143.2005.01180.x
|
| 11 |
Asmaa G. Abdou, Nancy Y. Asaad, Nermin Ehsan, Sheren Younes, Asmaa I. Gomaa, Walaa Elgendy. The Diagnostic Impact of C4d, CD68, and NF-κB Expression in the Differentiation Between Recurrent Hepatitis C and Acute Cellular Rejection After Liver Transplantation. Applied Immunohistochemistry & Molecular Morphology 2016; 24(9) doi: 10.1097/PAI.0000000000000245
|